Evidence map›Paper›PMID 34035797›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2021

Landscape of research, production, and regulation in venoms and antivenoms: a bibliometric analysis.

José Luis Di Fabio, María de Los Ángeles Cortés Castillo, Elwyn Griffiths

Abstract read
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Varespladib attenuatesRedox report : communications in free radical research · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

José Luis Di FabioIndependent consultant Washington D.C United States of America Independent consultant, Washington D.C., United States of America.
María de Los Ángeles Cortés CastilloIndependent consultant Mexico City Mexico https://orcid.org/0000-0003-0029-665x Independent consultant, Mexico City, Mexico, https://orcid.org/0000-0003-0029-665x.
Elwyn GriffithsIndependent consultant in Vaccines and Biotherapeutics Kingston upon Thames United Kingdom https://orcid.org/0000-0002-5801-2448 Independent consultant in Vaccines and Biotherapeutics, Kingston upon Thames, United Kingdom, https://orcid.org/0000-0002-5801-2448.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the productivity and visibility in research, clinical studies, treatment, use and production of antivenoms against poisonous snakes, scorpions and spiders.

methodsBibliometric analysis of research and other activities. Articles on venoms and antivenoms published between 2000 and 2020 were retrieved from the Scopus database. The records were analyzed by bibliometric indicators including number of documents per year, journals, authors, and citation frequency. VOSviewer

resultsAustralia, Brazil, Costa Rica and India were among the six top countries with most documents and were selected for more detailed analysis. Costa Rica was the country with the largest percentage of its publications dedicated to antivenom production and venomics. Only a few papers dealt with the issues of quality, safety, and efficacy of antivenoms or the role of the national regulatory authorities. The use of VOSviewe

conclusionsWorking in a collaborative and coordinated manner these four countries could have a major impact on envenoming globally. Attention should be given not only to antivenom production but also to strengthening regulatory oversight of antivenom products.

Indexed as

antivenomsbibliometricsSnakesspiders, scorpionsvenoms

Identifiers

PMID34035797
PMCPMC8139637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.